Lack of effect of naltrindole on the spinal synergism of morphine and non-steroidal anti-inflammatory drugs (NSAIDS)
Author
dc.contributor.author
Miranda, Hugo F.
Author
dc.contributor.author
Pinardi, Hugo F.
Admission date
dc.date.accessioned
2019-03-11T12:57:41Z
Available date
dc.date.available
2019-03-11T12:57:41Z
Publication date
dc.date.issued
2009
Cita de ítem
dc.identifier.citation
Journal of Physiology and Pharmacology, Volumen 60, Issue 2, 2018, Pages 71-76
Identifier
dc.identifier.issn
08675910
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164805
Abstract
dc.description.abstract
To enhance analgesia, combination of analgesics drugs of proven efficacy is a strategy which is accompanied by a reduction of adverse effects. The present study was undertaken to characterize the antinociceptive interaction of morphine with different non-steroidal anti-inflammatory drugs (NSAIDs) using isobolographic analysis and the writhing test of mice. One of the possible mechanisms of action of spinally administered morphine with non-steroidal antiinflammatory drugs was investigated using the DOR antagonist naltrindole. The study demonstrated a synergistic antinociception of spinal administered combinations of morphine with the following NSAIDs agents: diclofenac, ketoprofen, meloxicam, metamizol, naproxen, nimesulide, parecoxib and piroxicam. The supraadditive effect seems to be independent of the selectivity of each NSAIDs to inhibit COX-1 or COX-2. The findings of the present work suggest that the combinations of opioids and non-steroidal anti-inflammatory drugs have a direct a